On the Cusp of Completely Implantable Cochlear Implants
With several completely implantable CIs in development, a new device choice for patients with severe-to-profound hearing loss is on the horizon.
With several completely implantable CIs in development, a new device choice for patients with severe-to-profound hearing loss is on the horizon.
The bimodal neuromodulation device is now available through select hearing care clinics across five provinces.
Retraining the brain to hear after hearing loss is a game changer for patients, and gamified programs accessible by phone make the practice that much easier to incorporate into a hearing care plan.
New tools, including generative AI sentence completion, are designed to create smoother phone conversations for users with hearing loss or speech disabilities who type to communicate.
Developed by the National Acoustic Laboratories, the system builds on NAL-NL2 and is designed for more precise, personalized hearing aid fittings.
The pivotal clinical trial for the investigational device has now enrolled all 56 participants, moving the company closer to a potential FDA submission.
Neuromod Devices has partnered with HearConsult to introduce the bimodal neuromodulation system, addressing a reported 33% rise in tinnitus cases in the country.
In recognition of National Falls Prevention Awareness Month, Starkey is highlighting the critical link between hearing loss and increased fall risk and how advanced hearing technology can play a life-saving role.
The updated design aims to improve accessibility for seniors while remaining compliant with child-safety regulations.